![ADTAB 56 MG DOGS (1.3-2.5 KG) 1 BROWN CHEWABLE TABLET](https://complementosparaaves.com/6917-large_default/chewable-antiparasitic-for-dogs-adtab-from-15-kg-to-25-kg-1-unit.jpg)
Antiparasitario masticable para perros ADTAB de 2.5 kg a 5.5 kg, 1 ud
ADTAB CHEWABLE TABLETS FOR DOGS
Forget about annoying ticks and fleas, with this magnificent product!
![](/img/cms/opciones%20de%20compra.png)
![](/img/cms/visa_1.png)
![](/img/cms/Mastercard-logo-svg.png)
![](/img/cms/transferencia%20bancaria.png)
![](/img/cms/paypal.png)
![](/img/cms/seQura.png)
![](/img/cms/recibe%20tu%20pedido.png)
![](/img/cms/los%20mejores%20precios.png)
![](/img/cms/canal%20seguro%20de%20pago.png)
![](/img/cms/financia%20tu%20compra.png)
![](/img/cms/devoluciones%20de%20pago.png)
![ADTAB 112 MG DOGS (2.5-5.5 KG) 1 PINK CHEWABLE TABLET](https://complementosparaaves.com/6918-medium_default/chewable-antiparasitic-for-dogs-adtab-from-25-kg-to-55-kg-1-unit.jpg)
ADTAB CHEWABLE TABLETS FOR DOGS
Qualitative and quantitative composition
Active substance:
Each chewable tablet contains:
Dogs (1.3–2.5 kg): 56.25 mg Lotilaner
Dogs (>2.5-5.5 kg): 112.5 mg Lotilaner
Dogs (>5.5-11 kg): 225 mg Lotilaner
Dogs (>11-22 kg): 450 mg Lotilaner
Dogs (>22-45 kg): 900 mg Lotilaner
Excipients:
Qualitative composition of excipients and other constituents
Cellulose, powder
Lactose monohydrate
Silified microcrystalline cellulose
Dried meat flavor
Crospovidone
Povidone K30
Sodium lauryl sulfate
Silica, colloidal anhydrous
Magnesium stearate
White to beige round chewable tablets with brown spots.
Target species
Dogs.
Indications for use for each target species
Treatment of flea and tick infestations in dogs.
This veterinary medicinal product provides immediate and persistent action for a 1 month of elimination of fleas (Ctenocephalides felis and C. canis) and ticks (Rhipicephalus sanguineus, Ixodes ricinus, I. hexagonus and Dermacentor reticulatus).
Fleas and ticks must be attached to the host and carry out their food cycle to be exposed to the active ingredient.
Contraindications
Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Special warnings
Parasites must start feeding on the dog to be exposed to lotilaner; For this reason, the risk of contagion of parasitically transmitted diseases cannot be totally excluded.
The possibility that other animals in the same household may be a source of flea reinfection should be taken into account, and these should be treated as necessary with a suitable product.
All phases of fleas can infest dog bedding and usual resting areas such as carpets and furniture. In case of massive flea infestation and at the beginning of control measures, these areas should be treated with a suitable environmental product and then vacuumed regularly.
Special precautions for use
Special precautions for safe use in target species:
All efficacy and safety data have been acquired with puppies and dogs 8 weeks of age or older and weighing 1.3 kg or more. In the absence of available data, the veterinarian should be consulted before treating puppies less than 8 weeks of age or weighing less than 1.3 kg.
Specific precautions to be taken by the person administering the veterinary medicinal product to animals:
Wash hands after use of the product.
In case of accidental ingestion, seek medical advice immediately and show the package leaflet or label to the doctor.
Special precautions for environmental protection:
Not applicable.
Adverse events
Target species: Dogs
Very rare (<1 animal per 10 000 animals treated, including isolated reports)
Mild and transient. Usually resolves without treatment: Diarrhea, Vomiting and Anorexia
Usually resolves without treatment: lethargy
Transient in most cases: Ataxia, Seizures, Tremors
Reporting of adverse events is important. It allows continuous monitoring of the safety of a veterinary medicinal product. Notifications shall preferably be sent through a veterinarian to the marketing authorisation holder or to the national competent authority through the national notification system. See the "Contact details" section of the package leaflet.
Use during pregnancy, lactation or laying
The safety of the veterinary medicinal product has not been demonstrated during pregnancy, lactation or in breeding dogs.
Pregnancy and lactation:
Laboratory studies in rats have not demonstrated teratogenic effects or any adverse effects on the reproductive capacity of males and females. Consult the veterinarian before treatment during pregnancy and lactation.
Fertility:
Consult your veterinarian before treating breeding dogs.
Interaction with other medicinal products and other forms of interaction
None known. During clinical trials, no interactions have been observed between lotilaner and routinely used veterinary medicinal products.
Dosage and routes of administration
Orally.
The veterinary medicinal product should be administered according to the table below to ensure a dose of 20 to 43 mg lotilaner/kg body weight.
Body weight of the dog
(kg)
|
Dosage and number of tablets to be administered
|
||||
Lotilaner Elanco
56 mg
|
Lotilaner Elanco
112 mg
|
Lotilaner Elanco
225 mg
|
Lotilaner Elanco |
450 mg
Lotilaner Elanco
900 mg
1,3–2,5
1
>2.5–5.5
1
>5.5-11.0
1
>11.0-22.0
1
>22.0-45.0
1
>45
Appropriate combination of tablets
For dogs weighing more than 45 kg use an appropriate combination of available doses to achieve the recommended dose of 20–43 mg/kg.
Insufficient dosing could result in ineffective use and promote the development of resistance.
To ensure correct dosing, the weight must be determined as accurately as possible.
Lotilaner Elanco is a chewable tablet with a pleasant taste. Administer the chewable tablet(s) once a month during or after a meal.
For optimal control of tick and flea infestations, The veterinary medicinal product should be administered at monthly intervals and maintained throughout the flea or tick season depending on local epidemiological situations.
Overdose symptoms (and, where appropriate, emergency procedures and antidotes)
No adverse reactions have been observed during oral administration to puppies aged 8 to 9 weeks weighing 1.3–3.6 kg treated with overdosage up to 5 times the maximum recommended dose (43 mg, 129 mg and 215 mg lotilaner/kg body weight) on eight occasions at monthly intervals.
Restrictions and special conditions of use, including restrictions on the use of antimicrobial and antiparasitic veterinary medicinal products, in order to reduce the risk of development of resistance
Not applicable.
Waiting times
Not applicable.
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 3 years
Special precautions for storage
This veterinary medicinal product does not require any special storage conditions.
Classification of veterinary medicinal products
Medicinal product not subject to veterinary prescription.
![ADTAB 56 MG DOGS (1.3-2.5 KG) 1 BROWN CHEWABLE TABLET](https://complementosparaaves.com/6917-large_default/chewable-antiparasitic-for-dogs-adtab-from-15-kg-to-25-kg-1-unit.jpg)